Quantbot Technologies’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-11,205
Closed -$231K 1870
2022
Q3
$231K Buy
11,205
+5,625
+101% +$144K 0.02% 837
2022
Q2
$115K Buy
5,580
+830
+17% +$23.4K 0.01% 1105
2022
Q1
$204K Buy
4,750
+433
+10% +$19.5K 0.02% 857
2021
Q4
$258K Buy
+4,317
New +$346K 0.02% 672
2021
Q1
Sell
-460
Closed -$48K 1574
2020
Q4
$48K Sell
460
-1,060
-70% -$141K 0.01% 864
2020
Q3
$211K Buy
1,520
+793
+109% +$165K 0.02% 569
2020
Q2
$235K Buy
+727
New +$117K 0.03% 386
2016
Q4
Sell
-304
Closed -$34K 1183
2016
Q3
$34K Sell
304
-664
-69% -$73.4K ﹤0.01% 905
2016
Q2
$107K Buy
968
+944
+3,933% +$115K 0.01% 699
2016
Q1
$2K Sell
24
-91
-79% -$7.03K ﹤0.01% 1101
2015
Q4
$9K Buy
115
+7
+6% +$557 ﹤0.01% 985
2015
Q3
$7K Buy
+108
New +$9.41K ﹤0.01% 1106
2015
Q2
Sell
-246
Closed -$24K 1234
2015
Q1
$24K Buy
246
+121
+97% +$11.7K 0.01% 890
2014
Q4
$13K Buy
+125
New +$15.3K ﹤0.01% 992
2014
Q3
Sell
-633
Closed -$82K 1255
2014
Q2
$82K Buy
+633
New +$74.7K 0.01% 804

Other funds holding INO

Quantbot Technologies's INO Position: Q4 2022 in Review

Quantbot Technologies sold out of Inovio Pharmaceuticals (INO) in Q4 2022, closing a stake of 11,205 shares — an estimated $231K sold.

Quantbot Technologies first reported a position in INO in Q2 2014 and held it in 15 quarters. The position peaked at $258K in Q4 2021. 183 funds tracked by Wall St. Rank hold INO as of Q4 2022.

  • Quantbot Technologies reported no remaining Inovio Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Quantbot Technologies sold 11,205 Inovio Pharmaceuticals shares in Q4 2022, an estimated $231K.
  • Quantbot Technologies first reported a position in Inovio Pharmaceuticals in Q2 2014 and held it in 15 quarters.
  • Quantbot Technologies's Inovio Pharmaceuticals position peaked at $258K in Q4 2021.
  • 183 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2022.

Based on Quantbot Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.